<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="utf-8" />
    <meta content="IE=edge,chrome=1" http-equiv="X-UA-Compatible" />
    <meta content="width=device-width, initial-scale=1, maximum-scale=2, user-scalable=no" name="viewport" />
    <meta
        content="WHO Visualization dashboard shows the HBsAg prevalence estimates at global, regional and country level and how they have changed since hepatitis B vaccination was introduced."
        name="description" />
    <meta content="Hepatitis, vaccinations, research" name="keywords" />
    <meta content="@rgdonohue" name="author" />
    <title>WHO chronic HBV infections (prevalence of HBsAg) dashboard</title>
    <link rel="stylesheet" type="text/css" href="css/semantic.min.css">
    <link rel="stylesheet" type="text/css" href="css/dataTables.semanticui.min.css">
    <link href="https://fonts.googleapis.com/css?family=Lustria" rel="stylesheet">
    <link rel="stylesheet" type="text/css" href="css/style.css">
</head>

<body>
    <div class="ui fixed borderless inverted huge menu">
        <div class="ui container grid">

            <!-- DESKTOP MENU -->
            <div class="computer only row">
                <div class="header item"><img class="ui image" src="./images/who-logo-3.png"
                        alt="World Health Organization"></div>
                <a href="#public-health-strategies" class="item tab">Public Health Significance, Targets, Strategies</a>
                <a href="#global-strategies" class="item tab">Global and Country Estimates of immunization coverage and
                    chronic HBV infection</a>
                <a href="#hbv-country-profiles" class="item tab">HBV country profiles</a>
                <a href="#systematic-review" class="item tab">Methods used to estimate the hepatitis B surface antigen
                    prevalence</a>
            </div>

            <!-- MOBILE MENU -->
            <div class="tablet mobile only row">
                <a class="header item"><img class="ui image" src="./images/who-logo-3.png"
                        alt="World Health Organization"></a>
                <div class="right menu">
                    <a class="menu item">
                        <div class="ui basic icon inverted toggle button">
                            <i class="content icon"></i>
                        </div>
                    </a>
                </div>
                <div class="ui vertical accordion borderless inverted fluid menu">
                    <a href="#public-health-strategies" class="item tab">Public Health Significance, Targets,
                        Strategies</a>
                    <a href="#global-strategies" class="item tab">Global and Country Estimates of immunization coverage
                        and chronic HBV infection</a>
                    <a href="#hbv-country-profiles" class="item tab">HBV country profiles</a>
                    <a href="#systematic-review" class="item tab">Methods used to estimate the hepatitis B surface
                        antigen prevalence</a>
                </div>
            </div>
        </div>
    </div>

    <div class="ui container master-container">

        <div class="ui stackable grid container who-page" id="public-health-strategies">
            <div class="ui sixteen wide column">
                <h1 class="ui header">Public Health Significance, Targets, Strategies</h1>
                <h3 class="ui header">Goal</h3>
                <p>In May 2016, the World Health Assembly endorsed the Global Health Sector Strategy (GHSS) on viral
                    hepatitis
                    2016–2021. The GHSS calls for the elimination of viral hepatitis as a public health threat by 2030
                    (reducing
                    new infections by 90% and mortality by 65%).</p>
                <p>Most of the burden of disease from hepatitis B virus (HBV) infection comes from infections acquired
                    before
                    the age of 5 years. Therefore, prevention of HBV infection focuses on children under 5 years of age.
                    The United Nations selected the cumulative incidence of chronic HBV infection at 5 years of age as
                    an
                    indicator of the Sustainable Development Goal target for “combating hepatitis” . This indicator is
                    measured
                    indirectly through the proportion of children 5 years of age who have developed chronic HBV
                    infection
                    (i.e. the proportion that tests positive for a marker of infection called hepatitis B surface
                    antigen
                    [HBsAg]).</p>

                <h3 class="ui header">Global Health Sector Strategy on viral hepatitis</h3>
                <p>The strategy includes both impact (incidence and mortality) and service coverage target. By 2020,
                    five
                    million people will be receiving treatment for chronic hepatitis B virus infection and the number
                    of new cases of chronic hepatitis infection would have been reduced by 30% compared with the number
                    of new cases in 2015. By 2030, the incidence of chronic hepatitis infection will have been reduced
                    by 90% and there will be universal access to key prevention and treatment services.</p>
                <p>An early win in the global response to viral hepatitis was achieved through the effective scaling up
                    of hepatitis B vaccine. WHO recommends that all infants receive the hepatitis B vaccine as soon as
                    possible after birth, preferably within 24 hours. Birth-dose vaccination is a key intervention for
                    prevention of hepatitis B virus infection in infants. However, its delivery can be a challenge in
                    communities where a large proportion of births occur outside of health facilities. As a result,
                    global
                    coverage is only around 38% In 2015, global coverage with the three doses of hepatitis B vaccine
                    in infancy reached 84%. This has substantially reduced HBV transmission in the first five years of
                    life, as reflected by the reduction in HBV prevalence among children to 1.3%. Other prevention
                    interventions
                    are available but insufficiently implemented.</p>
                <p><a href="http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf?ua=1">Global
                        Hepatitis Report 2017</a></p>
                <p><a href="http://apps.who.int/iris/bitstream/10665/246177/1/WHO-HIV-2016.06-eng.pdf?ua=1">Global
                        Health Sector Strategy on Viral Hepatitis 2016 &ndash; 2017</a></p>

                <h3 class="ui header">Hepatitis B vaccine recommendations</h3>
                <p>WHO recommends that all infants receive the hepatitis B vaccine as soon as possible after birth,
                    preferably
                    within 24 hours. If administration within 24 hours is not feasible, a late birth dose has some
                    effectiveness.
                    Although effectiveness declines progressively in the days after birth, after 7 days, a late birth
                    dose can still be effective in preventing horizontal transmission and therefore remains beneficial.
                    WHO recommends that all infants receive the late birth dose during the first contact with
                    health-care
                    providers at any time up to the time of the next dose of the primary schedule.</p>
                <p>The birth dose should be followed by 2 or 3 doses to complete the primary series. In most cases, 1 of
                    the following 2 options is considered appropriate:</p>
                <ul class="ui list">
                    <li class="item">a 3-dose schedule of hepatitis B vaccine, with the first dose (monovalent) being
                        given at birth and
                        the second and third (monovalent or combined vaccine) given at the same time as the first and
                        third doses of diphtheria, pertussis (whooping cough), and tetanus – (DTP) vaccine; or</li>
                    <li class="item">a 4-dose schedule, where a monovalent birth dose is followed by three monovalent or
                        combined vaccine
                        doses, usually given with other routine infant vaccines. WHO Hepatitis B Vaccine position paper
                    </li>
                </ul>
                <p><a href="http://apps.who.int/iris/bitstream/10665/255841/1/WER9227.pdf?ua=1">WHO Hepatitis B Vaccine
                        position paper</a></p>

            </div>
            <div class="ui ten wide column">
                <h3 class="ui header">Global Immunization Coverage</h3>
                <img class="ui image" src="images/REGION-GLOBAL.jpg" alt="global vaccination coverage graphic" />
                <img class="ui image" src="images/legend-punchcard.jpg"
                    alt="global vaccination coverage graphic legend" />
                <ul class="ui list">
                    <li class="item"><a
                            href="http://www.who.int/immunization/monitoring_surveillance/data/en/">Immunization
                            surveillance assessment and monitoring</a></li>
                    <li class="item"><a href="http://apps.who.int/gho/data/node.wrapper.immunization-cov">Global Health
                            Observatory &ndash; Immunization coverage</a></li>
                </ul>
            </div>
        </div>

        <div class="ui container who-page" id="global-strategies">
            <div class="ui stackable grid">
                <div class="ui sixteen wide column">
                    <h1 class="ui header">Global and Country Estimates of immunization coverage and chronic HBV
                        infection</h1>
                    <h3 class="ui header">Hepatitis B HBsAg estimates, a baseline towards the elimination targets</h3>
                </div>

                <div class="ui six wide column">
                    <h4 class="ui header">Global Immunization 3rd dose of Hepatitis B (HepB3) coverage in infants and
                        Birth Dose of Hepatitis B in
                        newborns, 2000-2015</h4>
                    <img class="ui image" src="images/global-line-chart.png"
                        alt="Global Immunization 3rd dose of Hepatitis B (HepB3) coverage in infants and Birth Dose of Hepatitis B in newborns, 2000-2015" />
                    <div class="toggle-page2 ui buttons year-toggle">
                        <button class="est-2015 ui primary button">2015 est</button>
                        <div class="or"></div>
                        <button class="est-2019 ui button">2019 est</button>
                    </div>

                    <div class="ui small header">Global estimated HBsAg prevalence <br>(%, 95% CI<span class="asterisk">
                            *</span>)</div>
                    <canvas id="viz-global-a"></canvas>
                    <div class="ui grid">
                        <div class="eight wide column">
                            <div class="ui tiny header centered">Under 5 Yrs</div>
                        </div>
                        <div class="eight wide column">
                            <div class="ui tiny header centered">All Ages</div>
                        </div>
                    </div>
                    <div class="credible-interval"><span class="asterisk">*</span> credible intervals and ∙ indicates
                        upper and lower intervals</div>

                    <div class="toggle-page2 ui buttons year-toggle">
                        <button class="est-2015 ui primary button">2015 est</button>
                        <div class="or"></div>
                        <button class="est-2019 ui button">2019 est</button>
                    </div>

                    <div class="ui small header">Global estimated number of chronic HBV infection<br>(95% CI<span
                            class="asterisk"> *</span>)</div>
                    <canvas id="viz-global-b"></canvas>
                    <div class="ui grid">
                        <div class="eight wide column">
                            <div class="ui tiny header centered">Under 5 Yrs</div>
                        </div>
                        <div class="eight wide column">
                            <div class="ui tiny header centered">All Ages</div>
                        </div>
                    </div>
                    <div class="credible-interval"><span class="asterisk">*</span> credible intervals and ∙ indicates
                        upper and lower intervals</div>

                    <div class="toggle-page2 ui buttons year-toggle">
                        <button class="est-2015 ui primary button">2015 est</button>
                        <div class="or"></div>
                        <button class="est-2019 ui button">2019 est</button>
                    </div>

                    <div class="ui small header">Global estimated number of chronic HBV infection prevented <br>(95%
                        CI<span class="asterisk"> *</span>)</div>
                    <div id="pending"><i>data pending for 2019</i></div>
                    <div id='global-c-container'>
                        <canvas id="viz-global-c"></canvas>
                        <div class="ui grid">
                            <div class="eight wide column">
                                <div class="ui tiny header centered">Under 5 Yrs</div>
                            </div>
                            <div class="eight wide column">
                                <div class="ui tiny header centered">All Ages</div>
                            </div>
                        </div>
                        <div class="credible-interval"><span class="asterisk">*</span> credible intervals and ∙
                            indicates
                            upper and lower intervals</div>
                    </div>

                </div> <!-- end ui six wide column -->

                <div class="ui ten wide column">
                    <br>
                    <p>This dashboard shows the HBsAg prevalence estimates at global, regional and country level and how
                        they have
                        changed since hepatitis B vaccination was introduced.</p>
                    <p>This dataset represents the best estimates for the hepatitis B surface antigen indicator and aims
                        to facilitate
                        comparability across countries and over time. The estimates are not always the same as the
                        official national
                        estimates, because of the use of different methodologies and data sources. Estimates are
                        provided for
                        194 WHO Member States. The analysis was carried out for the age groups 0-5 years and for the
                        general
                        population. Due to scarcity of data from some countries, the estimates are more robust at global
                        and
                        regional level than at country level, therefore, we suggest countries focus on the 95% Credible
                        Intervals
                        and not only on the reported point estimates.</p>
                    <p>WHO’s estimates uses a methodology reviewed by the Immunization and Vaccines Related
                        Implementation Research
                        Advisory Committee (IVIR-AC) and presented to the Strategic Advisory Group of Experts (SAGE).
                        These estimates
                        have been documented following the Guidelines for Accurate and Transparent Health Estimates
                        Reporting
                        (GATHER). More detailed information on quality of data sources and methods, as well as estimated
                        uncertainty
                        intervals, is provided in the <a
                            href="http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf?ua=1">Global
                            Hepatitis Report 2017</a>,
                        the <a href="http://www.who.int/immunization/monitoring_surveillance/data/en/">WHO Immunization
                            surveillance, assessment and monitoring system</a>, the <a
                            href="http://who.int/immunization/diseases/hepatitisB/HBsAg_estimates_and_methods_final_V3.pdf?ua=1">estimations
                            of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data
                            published between 1965 and 2017</a>, and in other referenced sources.</p>
                    <p>WHO provided Member States the opportunity to review and comment on data and estimates as part of
                        the so
                        called country consultation process.</p>
                    <p>The database last update was 23 March 2017. Estimates will be updated as more recent or revised
                        data become
                        available, or when there are changes to the methodology being used. Next scheduled update will
                        be in
                        Q1 2018. Member States, civil society, country and regional offices that wish to contribute to
                        improve
                        the seroprevalence database can send their potential eligible published and unpublished reports
                        on surface
                        antigen prevalence to the following email: <a
                            href="mailto:VaccineResearch@who.int">VaccineResearch@who.int</a> until October 15, 2017.
                        They will be screened according to the inclusion criteria of the review. Potential
                        contributions received after this date will be considered in the next update exercise.</p>
                    <p><a href='docs/HBsAg_prevalence_2015.xlsx'>Hepatitis b surface antigen estimates and number of
                            carriers in 2015 in the general population</a>.</p>
                    <p><a href='docs/HBsAg_prevalence_2015_under5y.xlsx'>Hepatitis b surface antigen estimates and
                            number of carriers in 2015 in the under 5 years of age</a>.</p>
                    <p><a href='docs/HBsAg_prevalence_2020_under5y.xlsx'>Hepatitis b surface antigen estimates and
                            number of carriers in 2020 in the general population</a>.</p>
                    <p><a href='docs/HBsAg_prevalence_2020_under5y.xlsx'>Hepatitis b surface antigen estimates and
                            number of carriers in 2020 in the under 5 years of age</a>.</p>
                </div><!-- end ui ten wide column -->
            </div>
            <div class="ui container" id="map-container">
                <div class="ui stackable grid container">
                    <div class="ui ten wide column">
                        <div class="ui medium header">Hepatitis b surface antigen estimates in 2015 and in the
                            pre-vaccination era and number of carriers prevented in all ages and in the under 5 years
                            old population</div>
                    </div>
                    <div class="ui three wide column">
                        <div class="ui tiny header">Under 5 Yrs</div>
                        <div class="ui radio checkbox">
                            <input type="radio" name="radio" data-value="PreVer1U5EstPer" checked="checked">
                            <label>pre-vaccination</label>
                        </div>
                        <div class="ui radio checkbox">
                            <input type="radio" name="radio" data-value="PostVer1U5EstPer">
                            <label>2015 estimate</label>
                        </div>
                        <div class="ui radio checkbox">
                            <input type="radio" name="radio" data-value="PostVer2U5EstPer">
                            <label>2019 estimate</label>
                        </div>
                    </div>
                    <div class="ui three wide column">
                        <div class="ui tiny header">All Ages</div>
                        <div class="ui radio checkbox">
                            <input type="radio" name="radio" data-value="PreVer2GPEstPer">
                            <label>pre-vaccination</label>
                        </div>
                        <div class="ui radio checkbox">
                            <input type="radio" name="radio" data-value="PostVer1GPEstPer">
                            <label>2015 estimate</label>
                        </div>
                        <div class="ui radio checkbox">
                            <input type="radio" name="radio" data-value="PostVer2GPEstPer">
                            <label>2019 estimate</label>
                        </div>
                    </div>
                </div>
                <div id="map">
                    <svg></svg>
                    <div id="map-legend">
                        <div class="ui tiny header">Percent prevalence of Hepatitis</div>
                        <div><span id="legend1"></span>High endemicity (&ge; 8%)</div>
                        <div><span id="legend2"></span>High intermediate endemicity (5&#37; &ndash; 7%)</div>
                        <div><span id="legend3"></span>Low intermediate endemicity (2&#37; &ndash; 4%)</div>
                        <div><span id="legend4"></span>Low endemicity (&le; 2%)</div>
                        <div><span id="legend5"></span>no data</div>
                    </div>
                    <div id="who-map-logo"><img src="images/WHOlogoEN.png" alt="WHO image" /></div>
                </div>
                <div class="ui container">
                    <p>Disclaimer: The boundaries and names shown and the designations used on this map do not imply the
                        expression
                        of any opinion whatsoever on the part of the World Health Organization concerning the legal
                        status
                        of any country, territory, city or area or of its authorities, or concerning the delimitation of
                        its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which
                        there
                        may not yet be full agreement. © WHO 2016. All rights reserved.</p>
                    <p>HBsAg estimates, modelling conducted by the London School of Hygiene and Tropical Medicine.</p>
                </div>
            </div>
        </div>


        <div class="who-page" id="hbv-country-profiles">
            <div class="ui stackable grid container">
                <div class="ui sixteen wide column">
                    <h1 class="ui header">HBV country profiles</h1>
                </div>
                <div class="ui six wide column">
                    <div class="ui small header">Country Demographics &nbsp; &nbsp;
                        <div class="ui selection dropdown" id="year-dropdown">
                            <input type="hidden" name="year" value="2015">
                            <i class="dropdown icon"></i>
                            <div class="text">2015</div>
                            <div class="menu">
                                <div class="item" data-value="1990">1990</div>
                                <div class="item" data-value="1991">1991</div>
                                <div class="item" data-value="1992">1992</div>
                                <div class="item" data-value="1993">1993</div>
                                <div class="item" data-value="1994">1994</div>
                                <div class="item" data-value="1995">1995</div>
                                <div class="item" data-value="1996">1996</div>
                                <div class="item" data-value="1997">1997</div>
                                <div class="item" data-value="1998">1998</div>
                                <div class="item" data-value="1999">1999</div>
                                <div class="item" data-value="2000">2000</div>
                                <div class="item" data-value="2001">2001</div>
                                <div class="item" data-value="2002">2002</div>
                                <div class="item" data-value="2003">2003</div>
                                <div class="item" data-value="2004">2004</div>
                                <div class="item" data-value="2005">2005</div>
                                <div class="item" data-value="2006">2006</div>
                                <div class="item" data-value="2007">2007</div>
                                <div class="item" data-value="2008">2008</div>
                                <div class="item" data-value="2009">2009</div>
                                <div class="item" data-value="2010">2010</div>
                                <div class="item" data-value="2011">2011</div>
                                <div class="item" data-value="2012">2012</div>
                                <div class="item" data-value="2013">2013</div>
                                <div class="item" data-value="2014">2014</div>
                                <div class="item" data-value="2015">2015</div>
                                <div class="item" data-value="2016">2016</div>
                                <div class="item" data-value="2017">2017</div>
                                <div class="item" data-value="2018">2018</div>
                                <div class="item" data-value="2019">2019</div>
                            </div>
                        </div>
                    </div>
                    <!-- end item -->
                    <table class="ui celled table">
                        <tbody>
                            <tr>
                                <td>
                                    <div>Total Population <span id="total-pop-year"><span></div>
                                </td>
                                <td>
                                    <div id="chartA-total-pop"></div>
                                </td>
                            </tr>
                            <tr>
                                <td>
                                    <div>Total Population under 5 <span id="under-five-pop-years"><span></div>
                                </td>
                                <td>
                                    <div id="chartA-total-pop-u5"></div>
                                </td>
                            </tr>
                            <tr>
                                <td>
                                    <div>Births <span id="birth-years"><span></div>
                                </td>
                                <td>
                                    <div id="chartA-births"></div>
                                </td>
                            </tr>
                            <tr>
                                <td>
                                    <div>Infant Mortality <span id="infant-mortality-years"><span></div>
                                </td>
                                <td>
                                    <div id="chartA-infant-mortality"></div>
                                </td>
                            </tr>
                            <tr>
                                <td>
                                    <div>Urban Population <span id="urban-pop-years"><span></div>
                                </td>
                                <td>
                                    <div id="chartA-urban-population"></div>
                                </td>
                            </tr>
                            <tr>
                                <td>
                                    <div>Births attended by skilled health personnel *</div>
                                </td>
                                <td><span id="chartA-births-attended"></span>% <span
                                        id="chartA-births-attended-year"></span></td>
                            </tr>
                        </tbody>
                    </table>
                    <div class="source-footnotes">
                        <p>Source: <a href="https://esa.un.org/unpd/wpp/Download/Standard/Population/">United Nations,
                                Population Division</a>. The World Population Prospects - the 2017 revision". New York,
                            2017</p>
                        <p>Note: Births and Infant Mortality refers to five-year periods running from 1 July to 30 June
                            of the initial and final years.</p>
                        <p>* Births attended by skilled health personnel is from <a
                                href="http://apps.who.int/gho/data/node.main.REPWOMEN39?lang=en" target="_blank">WHO
                                Health Statistics 2017</a>. Data are scarce, comes from different years, and are not
                            available for every country.</p>
                    </div>

                    <div class="ui small header">Hepatitis B Vaccine Schedule</div>
                    <table class="ui celled table">
                        <tbody>
                            <tr>
                                <td>
                                    <div>HepB vaccine introduced nationwide</div>
                                </td>
                                <td>
                                    <div id="chartB-hepB-intro-year"></div>
                                </td>
                            </tr>
                            <tr>
                                <td>
                                    <div>HepB birth dose introduced</div>
                                </td>
                                <td>
                                    <div id="chartB-hepB-birth-year"></div>
                                </td>
                            </tr>
                            <tr>
                                <td>
                                    <div>Current schedule</div>
                                </td>
                                <td>
                                    <div id="chartB-schedule"></div>
                                </td>
                            </tr>
                            <tr>
                                <td>
                                    <div>HepB vaccine types</div>
                                </td>
                                <td>
                                    <div id="chartB-type"></div>
                                </td>
                            </tr>
                        </tbody>
                    </table>
                    <p>Source: <a target="_blank"
                            href="http://www.who.int/immunization/monitoring_surveillance/data/en/">http://www.who.int/immunization/monitoring_surveillance/data/en/</a>
                    </p>
                </div>
                <div class="ten wide column">

                    <div>In 2015, the global prevalence of HBV infection in the general population was 3.5%. Among those
                        born before the hepatitis B vaccine became available, the proportion of persons living with
                        chronic HBV infection remains high. Prevalence was the highest in the African (6.1%) and Western
                        Pacific regions (6.2%). Overall, about 257 million persons were living with HBV infection.
                        Assuming that women of reproductive age constitute 25.3% of the world’s population (United
                        Nations data), adults chronically infected may include 65 million women of childbearing age who
                        can potentially transmit HBV to their babies. The widespread use of hepatitis B vaccine in
                        infants has considerably reduced the incidence of new chronic HBV infections. Between the
                        pre-vaccine era (which, according to the year of introduction can range from the 1980s to the
                        early 2000s) and 2015, the proportion of children under 5 years of age who became chronically
                        infected fell from 4.7% to 1.3%.</div>
                    <br><br>

                    <div class="ui simple dropdown item" id="country-dropdown">
                        <span id="dropdown-current-country"><i class="ao flag"></i>Angola</span> <i
                            class="dropdown icon"></i>
                        <div class="menu">
                            <div class="item">
                                <i class="dropdown icon"></i> AFR
                                <div class="menu" id="menu-afro"></div>
                            </div>
                            <div class="item">
                                <i class="dropdown icon"></i> EMR
                                <div class="menu" id="menu-emro"></div>
                            </div>
                            <div class="item">
                                <i class="dropdown icon"></i> EUR
                                <div class="menu" id="menu-euro"></div>
                            </div>
                            <div class="item">
                                <i class="dropdown icon"></i> AMR/PAHO
                                <div class="menu" id="menu-paho"></div>
                            </div>
                            <div class="item">
                                <i class="dropdown icon"></i> SEAR
                                <div class="menu" id="menu-searo"></div>
                            </div>
                            <div class="item">
                                <i class="dropdown icon"></i> WPR
                                <div class="menu" id="menu-wpro"></div>
                            </div>
                        </div>
                    </div>
                    <div class="ui small header">Immunization coverage in infants with three doses of hepatitis b and
                        hepatitis b birth
                        dose vaccine (1990-2019)</div>
                    <canvas id="vizC"></canvas>
                    <p>Source: <a target="_blank"
                            href="http://www.who.int/immunization/monitoring_surveillance/data/en/">http://www.who.int/immunization/monitoring_surveillance/data/en/</a>
                    </p>
                </div>

            </div>
            <!-- end ui three column stackable grid -->

            <!-- VIZ D1 -->

            <div class="ui three column stackable grid container">
                <div class="ui large header container">Pre-vac &mdash; 2015/2019 estimation antigen data</div>
                <div class="toggle-page3 ui buttons year-toggle">
                    <button class="est-2015 ui primary button">2015 est</button>
                    <div class="or"></div>
                    <button class="est-2019 ui button">2019 est</button>
                </div>
                <div class="ui medium header container">Estimated Hepatitis B surface antigen prevalence</div>
                <div class="column">
                    <div class="ui small header"><span class="current-country"></span> estimated HBsAg prevalence
                        <br>(%, 95% CI<span class="asterisk"> *</span>)
                    </div>
                    <canvas id="vizD-1"></canvas>
                    <div class="ui grid">
                        <div class="eight wide column">
                            <div class="ui tiny header centered">Under 5 Yrs</div>
                        </div>
                        <div class="eight wide column">
                            <div class="ui tiny header centered">All Ages</div>
                        </div>
                    </div>
                </div>

                <div class="column">
                    <div class="ui small header"><span class="regional-group"></span> region estimated HBsAg prevalence
                        <br>(%, 95% CI<span class="asterisk"> *</span>)
                    </div>
                    <canvas id="vizD-1b"></canvas>
                    <div class="ui grid">
                        <div class="eight wide column">
                            <div class="ui tiny header centered">Under 5 Yrs</div>
                        </div>
                        <div class="eight wide column">
                            <div class="ui tiny header centered">All Ages</div>
                        </div>
                    </div>
                </div>

                <div class="column">
                    <div class="ui small header"><span class="income-group"></span> countries estimated HBsAg prevalence
                        (%, 95% CI<span class="asterisk"> *</span>)</div>
                    <canvas id="vizD-1c"></canvas>
                    <div class="ui grid">
                        <div class="eight wide column">
                            <div class="ui tiny header centered">Under 5 Yrs</div>
                        </div>
                        <div class="eight wide column">
                            <div class="ui tiny header centered">All Ages</div>
                        </div>
                    </div>
                </div>
                <div class="credible-interval"><span class="asterisk">*</span> credible intervals and ∙ indicates upper
                    and lower intervals</div>
            </div>

            <!-- VIZ D2 -->
            <div class="ui medium header container">Estimated number of Hepatitis B surface antigen carriers</div>
            <div class="toggle-page3 ui buttons year-toggle">
                <button class="est-2015 ui primary button">2015 est</button>
                <div class="or"></div>
                <button class="est-2019 ui button">2019 est</button>
            </div>
            <div class="ui three column stackable grid container">
                <div class="column">
                    <div class="ui small header"><span class="current-country"></span> estimated number of chronic HBV
                        infection <br>(95% CI<span class="asterisk"> *</span>)</div>
                    <canvas id="vizD-2"></canvas>
                    <div class="ui grid">
                        <div class="eight wide column">
                            <div class="ui tiny header centered">Under 5 Yrs</div>
                        </div>
                        <div class="eight wide column">
                            <div class="ui tiny header centered">All Ages</div>
                        </div>
                    </div>
                </div>
                <div class="column">
                    <div class="ui small header"><span class="regional-group"></span> region estimated number of chronic
                        HBV infection <br>(95% CI
                        <span class="asterisk"> *</span>)
                    </div>
                    <canvas id="vizD-2b"></canvas>
                    <div class="ui grid">
                        <div class="eight wide column">
                            <div class="ui tiny header centered">Under 5 Yrs</div>
                        </div>
                        <div class="eight wide column">
                            <div class="ui tiny header centered">All Ages</div>
                        </div>
                    </div>
                </div>
                <div class="column">
                    <div class="ui small header"><span class="income-group"></span> estimated number of chronic HBV
                        infection (95% CI<span class="asterisk"> *</span>)</div>
                    <canvas id="vizD-2c"></canvas>
                    <div class="ui grid">
                        <div class="eight wide column">
                            <div class="ui tiny header centered">Under 5 Yrs</div>
                        </div>
                        <div class="eight wide column">
                            <div class="ui tiny header centered">All Ages</div>
                        </div>
                    </div>
                </div>
                <div class="credible-interval"><span class="asterisk">*</span> credible intervals and ∙ indicates upper
                    and lower intervals</div>
            </div>

            <!-- VIZ D3 -->
            <div class="ui medium header container">Estimated number of hepatitis B surface antigen carriers prevented
            </div>
            <div class="toggle-page3 ui buttons year-toggle">
                <button class="est-2015 ui primary button">2015 est</button>
                <div class="or"></div>
                <button class="est-2019 ui button">2019 est</button>
            </div>
            <div class="ui three column stackable grid container">
                <div class="column">
                    <div class="ui small header"><span class="current-country"></span> estimated number of chronic HBV
                        infection prevented (95&#37; CI
                        <span class="asterisk"> *</span>)
                    </div>
                    <canvas id="vizD-3"></canvas>
                </div>

                <div class="column">
                    <div class="ui small header"><span class="regional-group"></span> region estimated number of chronic
                        HBV infection prevented (95%
                        CI
                        <span class="asterisk"> *</span>)
                    </div>
                    <canvas id="vizD-3b"></canvas>
                </div>

                <div class="column">
                    <div class="ui small header"><span class="income-group"></span> estimated number of chronic HBV
                        infection prevented (95% CI<span class="asterisk"> *</span>)</div>
                    <canvas id="vizD-3c"></canvas>
                </div>
                <div class="credible-interval"><span class="asterisk">*</span>credible intervals and ∙ indicates upper
                    and lower intervals</div>
            </div>

            <div class="ui container">
                <br>
                <div class="ui medium header">Serological surveys eligible for the systematic review:
                    &nbsp;&nbsp;&nbsp;<span class="current-country"></span> <span id="no-studies"
                        class="ui small header"> (No studies for this country at this time)</span></div>
                <table class="ui celled table" id="chartETable" cellspacing="0" width="100%">
                    <thead>
                        <tr>
                            <th>Level</th>
                            <th>Author, Date</th>
                            <th>Years</th>
                            <th>Ages</th>
                            <th>pHBsAg</th>
                            <th>Low CI (for HBsAg) </th>
                            <th>Hi CI (for HBsAg) </th>
                            <th>Country</th>
                            <th>ISO3</th>
                            <th>Region</th>
                            <th>IAA</th>
                            <th>Link to report</th>
                        </tr>
                    </thead>
                    <tbody></tbody>
                </table>

            </div>
        </div>
        <!-- end hbv country profiles -->


        <div class="ui container who-page" id="systematic-review">
            <h1 class="ui header">Methods used to estimate the hepatitis B surface antigen prevalence</h1>
            <div class="ui stackable two column grid">
                <div class="column">
                    <h3 class="ui header">Methods: Systematic review of surface antigen data published between 1965 and
                        2017</h3>
                    <p>We present national-level prevalence estimates of chronic HBV derived by a systematic review of
                        peer-reviewed literature reporting HBV prevalence (hepatitis B surface antigen [HBsAg]) in
                        children under 5 years of age and the general population. We updated the systematic review
                        conducted by Schweitzer, et al., 2015. It included a systematic search on articles published
                        between Jan 1, 1965, and Oct 23, 2013.
                        We updated the systematic search on articles published between Oct 23, 2013, and March 20, 2017
                        and searched the databases Embase, PubMed, Global Index Medicus, Popline, and Web of Science.
                        The inclusion/exclusion criteria were similar to (Schweitzer, et al.). Observational studies on
                        chronic HBV infection seroprevalence (HBsAg prevalence), done in the general population or among
                        blood donors, health-care workers (HCWs), and pregnant women were considered for inclusion in
                        this systematic review. Studies were if they were systematic reviews or meta-analyses,
                        surveillance reports, case studies, letters or correspondence, or did not contain HBsAg
                        seroprevalence data. Studies were also excluded if they exclusively reported prevalence
                        estimates for high-risk population groups (e.g., migrants and refugees).</p>
                </div>
                <div class="column">
                    <h3 class="ui header">Model to estimate the surface antigen prevalence</h3>
                    <p>The data was modelled using a logistic regression, weighting each study by its size and using a
                        conditional
                        autoregressive model accounting for spatial and economic correlations between similar countries.
                        The response variable in the model was the prevalence of Hepatitis surface antigen (HBsAg) with
                        the
                        predictor variables being age (three categories, under 5, juvenile (5-15) and adult (16+), split
                        using the average age of participants in the study), sex (proportion female in the study), study
                        bias (e.g. a high fraction of study participants from indigenous populations), 3 dose vaccine
                        coverage,
                        birth dose of the vaccine and country of study.</p>
                    <p>The model was simulated in the Bayesian statistical package WinBUGS, and data manipulation and
                        model
                        initialisation run from R (3.3.1) using R2WinBUGS. We considered the parameters of age, sex,
                        study
                        bias (e.g. a high fraction of study participants from indigenous populations), vaccine coverage,
                        birth dose of the vaccine and country of study. The coverage of routine 3 dose vaccination and
                        birth
                        dose vaccination was calculated by cross referencing the year of and age of participants in each
                        study with the corresponding WHO-UNICEF vaccine coverage estimates for that country.</p>
                    <p>We used the CAR-normal function, in WinBUGS, to model the spatial and developmental
                        autocorrelation related
                        to neighbouring countries. For each country for which we had prevalence data a weighted central
                        position
                        was calculated using the size and location of each study. For those with no data, we used the
                        population
                        centroid. In a novel approach, we considered 3 dimensions in the country proximity matrix; we
                        used
                        the usual geographic dimensions, latitude and longitude and also combined these with the natural
                        log of the country’s GDP per capita.</p>
                    <p><a
                            href="http://who.int/entity/immunization/diseases/hepatitisB/HBsAg_estimates_and_methods_final_V3.pdf?ua=1">Estimations
                            of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data
                            published between 1965 and 2017</a></p>
                    <p><img class="ui image left floated" src="./images/lshtm-logo.png"
                            alt="London SChool of Hygiene &amp; Tropical Medicine">Acknowledgements
                        to the London School of Hygiene and Tropical Medicine who conducted the modelling of the
                        hepatitis
                        B surface antigen estimates.</p>
                </div>
            </div>
        </div>

    </div> <!-- end master container -->

    <div class="ui footer basic segment">
        <div class="ui container">
            <p>
                Dashboard designed and built by <a href="https://github.com/rgdonohue/who-hepB-dashboard">@rgdonohue</a>
                and @mattzook.
            </p>
        </div>
    </div>


    <div id="map-hover-output">
        <div id="map-hover-country" class="ui inverted header"></div>
        <div>&lt; 5 years old HBsAg prevalence in the pre-vaccination (%, 95CI): <span id="map-hover-under-pre"
                class="ui inverted medium header right floated"></span></div>
        <div>&lt; 5 years old HBsAg prevalence in 2015 (%, 95CI): <span id="map-hover-under-2015"
                class="ui inverted medium header right floated"></span></div>
        <div>General population HBsAg prevalence in the pre-vaccination (%, 95CI): <span id="map-hover-general-pre"
                class="ui inverted medium header right floated"></span></div>
        <div>General population HBsAg prevalence in 2015 (%, 95CI): <span id="map-hover-general-2015"
                class="ui inverted medium header right floated"></span></div>
        <div>Number of carriers prevented in the &lt; 5 years (number, 95%CI): <span id="map-hover-u5-prevented"
                class="ui inverted medium header right floated"></span></div>
        <div>Number of carriers prevented in the general population (number, 95%CI): <span id="map-hover-gp-prevented"
                class="ui inverted medium header right floated"></span></div>
    </div>

    <script src="js/jquery-3.1.1.min.js"></script>
    <script src="js/semantic.min.js"></script>
    <script src="js/jquery.dataTables.min.js"></script>
    <script src="js/Chart.min.js"></script>
    <script src="js/d3.v4.min.js"></script>
    <script src="js/d3-geo-projection.v2.min.js"></script>
    <script src="js/topojson.min.js"></script>
    <script src="js/main.js"></script>
</body>

</html>